Literature DB >> 3787893

Characteristics of spinal cord compression in adenocarcinoma of prostate.

D A Kuban, A M el-Mahdi, S V Sigfred, P F Schellhammer, T J Babb.   

Abstract

Of 611 patients with biopsy-proved adenocarcinoma of the prostate, spinal cord compression developed in 41 (6.7%) at a median interval of twenty-four months after primary diagnosis. Spinal cord involvement most often occurred in the thoracic area, with 95 per cent of patients showing radiographic evidence of osseous vertebral metastasis at the level of cord compression. All lesions but one were located extradurally, and patients with Stage D2 disease, by virtue of bony metastases, were therefore at greatest risk for development of neurologically compressive disease. There was also a significant increase in the incidence of spinal cord involvement among the more poorly differentiated tumors, although tumor histology did not appear to influence the median interval between vertebral metastasis and cord compromise. Survival following spinal cord involvement was relatively poor and unrelated to tumor differentiation. Forty-six per cent of patients survived less than six months and 20 per cent less than two months. The two most noteworthy survivors are alive at thirty and ninety-seven months, the latter after combined treatment for an intradural lesion.

Entities:  

Mesh:

Year:  1986        PMID: 3787893     DOI: 10.1016/0090-4295(86)90062-2

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Spinal leptomeningeal metastases from prostate cancer.

Authors:  R Deinsberger; R Regatschnig; B Kaiser; H C Bankl
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

Review 2.  [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].

Authors:  K Heine; J M Wolff
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

3.  Dural metastases responsible for benign vertebral collapses.

Authors:  Bich-Ngoc-Thanh Tang; Didier Blocklet; Camilo Garcia; Rodrigo Moreno-Reyes; Bernard Stallenberg; Serge Goldman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06-22       Impact factor: 9.236

4.  Hormonal treatment of symptomatic spinal cord compression in advanced prostatic cancer.

Authors:  I Sasagawa; H Gotoh; H Miyabayashi; O Yamaguchi; Y Shiraiwa
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

Review 5.  Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review.

Authors:  Ruben Van den Brande; Erwin Mj Cornips; Marc Peeters; Piet Ost; Charlotte Billiet; Erik Van de Kelft
Journal:  J Bone Oncol       Date:  2022-07-09       Impact factor: 4.491

Review 6.  Spinal cord compression in prostate cancer.

Authors:  J L Osborn; R H Getzenberg; D L Trump
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Outcome after limited posterior surgery for thoracic and lumbar spine metastases.

Authors:  B Jónsson; L Sjöström; C Olerud; I Andréasson; J Bring; W Rauschning
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

8.  Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer.

Authors:  Sead Crnalic; Christer Hildingsson; Pernilla Wikström; Anders Bergh; Richard Löfvenberg; Anders Widmark
Journal:  Acta Orthop       Date:  2011-06-10       Impact factor: 3.717

9.  Update in palliative management of hormone refractory cancer of prostate.

Authors:  Pratipal Singh; Aneesh Srivastava
Journal:  Indian J Urol       Date:  2007-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.